October 5, 2015 : DCMS #261

DISASTERS AVERTED — Near Miss Case Studies

New Shoes Weren’t Made for Walking

HOMERUN SLIDES — Great Clinical Presentation Highlights

The Present and Future of Insulin Therapy, Part 10

CLINICAL GEMS — The Best from Diabetes Texts

Practical Diabetes Care, 3rd Ed., Excerpt #33: Lipids Part 3 of 6

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Keith Campbell, Part 3: Personal Experience and the Search for a Cure

TOP SHARED ARTICLES OF THE MONTH

#1 First Type 1 Patient in Trial No Longer Requires Insulin Therapy

#2 The Effects of Extra Virgin Olive Oil on Post-Prandial Glucose

#3 Bacterial Link Between Heart Disease and Gum Disease Clarified

As a diabetes educator and pharmacist, I have had a lot of success helping patients improve their diabetes care. But at the end of the day, I get to go home diabetes free. This week, one of my pals and a pharmacist educator is sharing his professional and personal opinions with us. Regardless of how much compassion we have for our patients, it is hard to even come close to what Dr. Keith Campbell offers them. Dr. Campbell has had type one diabetes for over 50 years and has been helping patients for almost that long. This week, he shares his insights, with Joy Pape, our associate medical editor, on how the management of diabetes has changed over his career and how that has affected him and his patients. Just as an example, Keith had to manage his diabetes for years without the benefit of a glucose meter, but now he can use a CGM.

Just like diabetes care changes for the better, we at Diabetes In Control are changing to make your experience better. We relaunched the new DiabetesInControl.com. The refreshed site features a clean, new look and feel, with enhanced navigation to make it even easier to find all our great content. We’ve also decided to make some of our most popular content, including our “Tools for Your Practice,” subscriber-exclusive to reward our loyal readers. In order to access this content, you will need to register your subscription email  on the new website.

Announcements:

Enter the Diabetes In Control contest! We’d like to hear your best suggestions to help prevent insulin errors at home, at pharmacies, and in the hospital. The contestant who submits the winning idea will receive a $100 Amazon gift card! Click here for more information and to enter! You may submit as many entries as you wish. Deadline to enter is November 1^st.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

Female, 32 years of age, type 1 diabetes, presented with Stage II partial thickness ulcer between 1st and 2nd toe R foot, and several Stage I areas on both feet. She had recently traveled and had bought several pair of new shoes for her trip.

In this week’s Homerun Slides, we look at the pro and contra arguments for forcing of early Insulin Therapy in patients with Type 2 Diabetes…

Simple screening tests will identify most secondary causes of hyperlipidemia.

This week, Associate Medical Editor Joy Pape wraps up her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he talks about his 60+ years of experience as a type 1 diabetes patient and how what he has learned over the years influences his view of his diabetes today.

The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first patient in its clinical trial has been free from insulin injections in record time following the implantation of islet cells within a biological scaffold. The patient, Wendy Peacock, 43, from San Antonio, …

A Mediterranean diet is considered to be ideal for healthy nutrition. It is typically composed of fruits, vegetables, cereals, fish, moderate wine consumption, and limited intake of dairy products and red meat. Furthermore, there are several studies showing that this type of diet is connected with reduced risk of cardiovascular events. Therefore, a Mediterranean-style diet …

A bacterial species common to both diseases increases arterial inflammation by altering gene expression.